A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

1,009

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
AsthmaCoronary Artery DiseasePulmonary Disease, Chronic Obstructive
Interventions
DRUG

Regadenoson

IV

DRUG

Placebo

IV

Trial Locations (48)

19013

Upland

19713

Newark

19807

Wilmington

27607

Raleigh

29303

Spartanburg

29407

Charleston

29615

Greenville

29640

Easley

30281

Stockbridge

32720

DeLand

32789

Winter Park

33173

Miami

33756

Clearwater

34655

Trinity

36117

Montgomery

37920

Knoxville

44024

Chardon

45206

Cincinnati

45231

Cincinnati

55402

Minneapolis

55441

Plymouth

60504

Aurora

63141

St Louis

66606

Topeka

68046

Papillion

71104

Shreveport

73103

Oklahoma City

75231

Dallas

77074

Houston

78130

New Braunfels

78229

San Antonio

90806

Long Beach

92024

Encinitas

92120

San Diego

92123

San Diego

92647

Huntington Beach

92691

Mission Viejo

92704

Santa Ana

92801

Anaheim

92835

Fullerton

95661

Roseville

97504

Medford

98105

Seattle

06708

Waterbury

04210

Auburn

02747

No. Dartmouth

08723

Brick

02906

Providence

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY